Red Mountain Financial’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,300
Closed -$274K 68
2024
Q3
$274K Buy
2,300
+30
+1% +$4K 0.29% 50
2024
Q2
$324K Buy
+2,270
New +$301K 0.39% 45
2023
Q4
$249K Buy
+2,410
New +$238K 0.39% 53

Other funds holding NVO

Red Mountain Financial's NVO Position: Q4 2024 in Review

Red Mountain Financial sold out of Novo Nordisk (NVO) in Q4 2024, closing a stake of 2,300 shares — an estimated $274K sold.

Red Mountain Financial first reported a position in NVO in Q4 2023 and held it in 3 quarters. The position peaked at $324K in Q2 2024. 1,665 funds tracked by Wall St. Rank hold NVO as of Q4 2024.

  • Red Mountain Financial reported no remaining Novo Nordisk position as of Q4 2024 after selling out during the quarter.
  • Red Mountain Financial sold 2,300 Novo Nordisk shares in Q4 2024, an estimated $274K.
  • Red Mountain Financial first reported a position in Novo Nordisk in Q4 2023 and held it in 3 quarters.
  • Red Mountain Financial's Novo Nordisk position peaked at $324K in Q2 2024.
  • 1,665 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2024.

Based on Red Mountain Financial's 13F filing for Q4 2024, filed 12 Feb 2025.